Hospital-Acquired Candidemia in HIV-Infected Patients. Incidence, Risk Factors and Predictors of Outcome

REFERENCES

• Beck-Sague C, Jarvis WR. Secular trends in the epi-demiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247–1251.
   PubMed Web of Science ®Google Scholar
• McNeil MM. Candida. In: Mayhall CG, Eds. Hospital epidemiology and infection control. Williams & Wilkins, Baltimore 1996: 408-419.
   Google Scholar
• Maenza JR, Merz WG. Candida albicans and related species. In: Gorbach SL, Bartlett JG, Blacklow NR, Eds. Infectious Diseases. WB Saunders Company, Philadelphia 1998; 2313–2321.
   Google Scholar
• Jarvis WR. Epidemiology of nosocomial fungal infec-tions, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–1530.
   PubMed Web of Science ®Google Scholar
• Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidaemia: the attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642–2645.
   PubMed Web of Science ®Google Scholar
• Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627–30
   PubMed Web of Science ®Google Scholar
• Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639–644.
   Google Scholar
• Garbino J, Kolarova L, Rohner P, Lew D, Pichna P, Pittet D. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 2002; 81: 425–33
   PubMed Web of Science ®Google Scholar
• Nolla-Salas J, Sitges-Sera A. Candidaemia in non-neu-tropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997; 23: 23–30.
   PubMed Web of Science ®Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002; 113: 480–85
   PubMed Web of Science ®Google Scholar
• Vincent JL. Microbial resistance: lessons from EPIC study. Intensive Care Med 2000; 26: S 3–8.
   Google Scholar
• Uzun O, Ascioglu S, Anaissie EJ, Rex JH. Risk factors and predictors of outcome in patients with cancer and break-through candidemia. Clin Infect Dis. 2001; 32: 1713–7
   PubMed Web of Science ®Google Scholar
• Giamarellou H, Antoniadou A. Epidemiology, diagno-sis, and therapy of fungal infections in surgery. Infect Control Hosp Epidemiol 1996; 17: 558–64
   PubMed Web of Science ®Google Scholar
• Polis MA, Kovacs JA. Fungal infections in patients with acquired immunodeficiency syndrome. In: De Vita VT, Hellman S, Rosenberg SA, Eds. AIDS. Etiology diagnosis, treatment and prevention. Lippincott-Raven, Philadelphia 1997; 231-244.
   Google Scholar
• Reef SE, Mayer KH. Opportunistic candidal infections in patients infected with human immunodeficiency virus: pre-vention issues and priorities. Clin Infect Dis 1995; 21 (suppl 1): S99-102
   Google Scholar
• Frank U, Daschner FD, Schulgen G, Mills J. Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 25: 318–320.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995; 31: 123–131
   PubMedGoogle Scholar
• Tumbarello M, Tacconelli E, de Gaetano Donati K, Citton R, Leone F, Spanu T, Cauda R. HIV-associated bac-teremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145–151.
   PubMed Web of Science ®Google Scholar
• Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L. Candidemia: a nosocomial compli-cation in adults with late-stage AIDS. Clin Infect Dis 1998; 26: 1134–41.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Tacconelli E, de Gaetano Donati K, Morace G, Fadda G, Cauda R. Candidemia in HIV-infected subjects. Eur J Clin Microbiol Infect Dis 1999; 18: 478–83.
   PubMed Web of Science ®Google Scholar
• Garbino J, Kolarova L, Lew D, Hirschel B, Rohner P. Fungemia in HIV infected patients: a 12 year study in a ter-tiary care hospital. Aids Patient Care 2001; 8: 407–10
   Web of Science ®Google Scholar
• Tortorano AM, Biraghi E, Astolfi A, et al. European confederation of medical mycology (ECMM) prospective sur-vey of candidaemia: report from one Italian region. J Hosp Infect 2002; 4: 297–304.
   Web of Science ®Google Scholar
• Morace G, Pagano L, Sanguinetti M, et al. PCR-restric-lion enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies. J Clin Microbiol 1999; 37: 1871–1875
   PubMed Web of Science ®Google Scholar
• Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (ed.). Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C. 1999.
   Google Scholar
• Centers for Disease Control. 1993 Revised classifica-tion system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41 (RR17): 1-19.
   Google Scholar
• Sallah S, Wan JY, Nguyen NP, Vos P, Sigounas G. Analysis of factors related to the occurrence of chronic dis-seminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer 2001; 92 :1349–53.
   PubMed Web of Science ®Google Scholar
• Kralovicova K, Spanik S, Oravcova E, et al. Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, aetiology and outcome. Scand J Infect Dis 1997; 29: 301–304.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Tumbarello M, Pittiruti M, et al. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis 1997; 16: 203–209.
   PubMed Web of Science ®Google Scholar
• Moore DA, Gazzard BC, Nelson MR. Central venous line infections in AIDS. J Infect 1997; 43: 35–40.
   Web of Science ®Google Scholar
• Ryan JA, Abel RH, Abbott WM, et al. Catheter com-plications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med 1974; 290: 757–761.
   Google Scholar
• Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197–208.
   PubMed Web of Science ®Google Scholar
• Weese-Mayer DE, Fondriest DW, Brouillette RT, Shulman ST. Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987; 6: 190–196.
   PubMed Web of Science ®Google Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751–758.
   PubMed Web of Science ®Google Scholar
• Moller J, Skinhoj P, Hoiby N. Microbial colonization and infectious complications in bone marrow transplant recipi-ents treated in strict protective isolation. Scand J Infect Dis 1984; 16: 43–50.
   PubMedGoogle Scholar
• Kennedy MJ, Voltz PA. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 1985; 23: 265–273.
   PubMedGoogle Scholar
• Kennedy MJ, Voltz PA. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun 1985; 49: 654–663.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Caldarola G, Tacconelli E, et al. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. J Antimicrob Chemother 1996; 38: 691–699.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Bertagnolio S, Posteraro B, et al. Azole susceptibility patterns and genetic relationship among oral Candida strains isolated in the era of highly active antiretrovi-ral therapy. J Acquir Immune Defic Syndr 2002; 31: 38–44.
   PubMed Web of Science ®Google Scholar
• Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of haematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–1128.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Martino P, De Bernardis F, et al. Rising incidences of Candida parapsilosis fungemia in patients with haematological malignancies: clinical aspects, predisposing fac-tors, and differential pathogenicity of the causative strains. Clin Infect Dis 1996; 23: 506–514.
   PubMed Web of Science ®Google Scholar
• Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984; 77: 20–27.
   PubMed Web of Science ®Google Scholar
• Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875–883.
   PubMed Web of Science ®Google Scholar